|
1
|
Bi J, Lau SH, Hu L, et al: Downregulation
of ZIP kinase is associated with tumor invasion, metastasis and
poor prognosis in gastric cancer. Int J Cancer. 124:1587–1593.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng L, Pu J, Jiang G, Weng M, He J, Mei
H, Hou X and Tong Q: Abnormal expression of early growth response 1
in gastric cancer: association with tumor invasion, metastasis and
heparanase transcription. Pathol Int. 60:268–277. 2010. View Article : Google Scholar
|
|
3
|
Stetler-Stevenson WG: The role of matrix
metalloproteinases in tumor invasion, metastasis, and angiogenesis.
Surg Oncol Clin N Am. 10:383–392. 2001.PubMed/NCBI
|
|
4
|
Lawson JD, Sicklick JK and Fanta PT:
Gastric cancer. Curr Probl Cancer. 35:97–127. 2011. View Article : Google Scholar
|
|
5
|
Watanabe H: Extracellular matrix –
regulation of cancer invasion and metastasis [J]. Gan To Kagaku
Ryoho. 37:2058–2061. 2010.
|
|
6
|
Gialeli C, Theocharis AD and Karamanos NK:
Roles of matrix metalloproteinases in cancer progression and their
pharmacological targeting. FEBS J. 278:16–27. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jin X, Yagi M, Akiyama N, Hirosaki T,
Higashi S, Lin CY, Dickson RB, Kitamura H and Miyazaki K:
Matriptase activates stromelysin (MMP-3) and promotes tumor growth
and angiogenesis. Cancer Sci. 97:1327–1334. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zinzindohoué F, Lecomte T, Ferraz JM,
Houllier AM, Cugnenc PH, Berger A, Blons H and Laurent-Puig P:
Prognostic significance of MMP-1 and MMP-3 functional promoter
polymorphisms in colorectal cancer. Clin Cancer Res. 11:594–599.
2005.PubMed/NCBI
|
|
9
|
Fiedorczyk M, Klimiuk PA, Sierakowski S,
Domyslawska l and Chwiecko J: Correlations between serum matrix
metalloproteinase (MMP-1, MMP-3, MMP-9, MMP-13) concentrations and
markers of disease activity in early rheumatoid arthritis. Przegl
Lek. 62:1321–1324. 2005.
|
|
10
|
Pietruszewska W, Kobos J, Gryczyński M,
Durko T and Bojanowska-Pożniak K: Analysis of TIMP-1, TIMP-2 and
TIMP-3 expression as a prognostic factor of laryngeal cancer
progression. Otolaryngol Pol. 62:380–387. 2008.PubMed/NCBI
|
|
11
|
Lee MH, Atkinson S and Murphy G:
Identification of the extracellular matrix (ECM) binding motifs of
tissue inhibitor of metalloproteinases (TIMP)-3 and effective
transfer to TIMP-1. J Biol Chem. 282:6887–6898. 2007.PubMed/NCBI
|
|
12
|
Li YH, Shao JY, Li S, Zou BY, Huang HQ and
Guan ZZ: Clinical significance of quantitative analysis of serum
VEGF, CD44s, and MMP-3 protein in nasopharyngeal carcinoma. Ai
Zheng. 23:1060–1064. 2004.PubMed/NCBI
|
|
13
|
Argüello-Ramírez J, Pérez-Cárdenas E,
Delgado-Chávez R, Solorza-Luna G, Villa-Trevińo S and
Arenas-Huertero F: Matrix metalloproteinases-2, -3, and -9 secreted
by explants of benign and malignant lesions of the uterine cervix.
Int J Gynecol Cancer. 14:330–340. 2004.PubMed/NCBI
|
|
14
|
Mylona E, Magkou C, Giannopoulou I,
Agrogiannis G, Markaki S, Keramopoulos A and Nakopoulou L:
Expression of tissue inhibitor of matrix metalloproteinases
(TIMP)-3 protein in invasive breast carcinoma: relation to tumor
phenotype and clinical outcome. Breast Cancer Res. 8:R572006.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mino N, Takenaka K, Sonobe M, Miyahara R,
Yanagihara K, Otake Y, Wada H and Tanaka F: Expression of tissue
inhibitor of metalloproteinase-3 (TIMP-3) and its prognostic
significance in resected non-small cell lung cancer. J Surg Oncol.
95:250–257. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Işlekel H, Oktay G, Terzi C, Canda AE,
Fűzűn M and Kűpelioğlu A: Matrix metalloproteinase-9,-3 and tissue
inhibitor of matrix metalloproteinase-1 in colorectal cancer:
relationship to clinicopathological variables. Cell Biochem Funct.
25:433–441. 2007.PubMed/NCBI
|
